Outcome | Group | Baseline | 5 weeks | 13 weeks | ||||
---|---|---|---|---|---|---|---|---|
 |  | Mean (SD) | Mean (SD) | P a | LSMD (95 % CI)a | Mean (SD) | P a | LSMD (95 % CI)a |
FSS | A | 4.67 (1.27) | 3.38 (1.01) | 0.023 | −0.43 (−0.81, −0.05) | 3.34 (1.17) | 0.075 | −0.36 (−0.74, 0.03) |
B | 4.75 (1.07) | 3.58 (1.12) | 0.151 | −0.29 (−0.66, 0.08) | 3.51 (1.19) | 0.290 | −0.23 (−0.62, 0.15) | |
C | 4.48 (1.27) | 4.47 (1.18) | - | - | 4.28 (1.24) | - | - | |
SRI-short form | A | 62.56 (17.95) | 42.21 (14.18) | 0.032 | −6.01 (−11.58, −0.44) | 42.28 (14.33) | 0.037 | −6.19 (−12.06, −0.31) |
B | 55.67 (14.40) | 42.10 (13.66) | <0.001 | −9.33 (−14.72, −3.95) | 39.81 (13.55) | <0.001 | −10.80 (−16.49, −5.12) | |
C | 60.04 (18.16) | 56.47 (18.03) | - | - | 57.41 (20.46) | - | - | |
BDI | A | 16.41 (8.36) | 9.02 (6.92) | 0.252 | −1.56 (−3.94, 0.83) | 9.63 (6.39) | 0.231 | −1.68 (−4.16, 0.81) |
B | 15.00 (7.67) | 8.88 (7.66) | 0.052 | −2.34 (−4.70, 0.02) | 7.89 (7.15) | 0.007 | −3.25 (−5.71, −0.80) | |
C | 15.30 (7.05) | 13.36 (6.39) | - | - | 14.28 (8.54) | - | - | |
NRS | A | 6.59 (1.44) | 4.42 (1.98) | <0.001 | −0.92 (−1.45, −0.40) | 4.77 (2.22) | 0.011 | −0.70 (−1.26, −0.14) |
B | 6.55 (1.27) | 4.52 (1.70) | <0.001 | −0.90 (−1.42, −0.39) | 4.51 (1.95) | 0.002 | −0.85 (−1.40, −0.29) | |
C | 6.40 (1.40) | 6.53 (1.36) | - | - | 6.42 (1.69) | - | - | |
EQ-5D | A | 0.84 (0.10) | 0.91 (0.11) | 0.909 | −0.01 (−0.04, 0.03) | 0.92 (0.11) | 0.844 | 0.01 (−0.03, 0.04) |
B | 0.87 (0.09) | 0.91 (0.09) | 0.522 | 0.01 (−0.02, 0.05) | 0.94 (0.08) | 0.074 | 0.03 (0.00, 0.07) | |
C | 0.88 (0.11) | 0.88 (0.10) | - | - | 0.87 (0.15) | - | - |